Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
ALI HEALTH
00241
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -49.03%60.93M | -3.55%177.55M | 178.82%119.53M | -22.92%184.09M | -68.04%42.87M | 56.51%238.84M | 19.97%134.12M | -44.72%152.6M | -13.10%111.79M | 403.82%276.04M |
| Operating income | -49.03%60.93M | -3.55%177.55M | 178.82%119.53M | -22.92%184.09M | -68.04%42.87M | 56.51%238.84M | 19.97%134.12M | -44.72%152.6M | -13.10%111.79M | 403.82%276.04M |
| Cost of sales | 50.61%-54.35M | -6.18%-161.64M | -202.24%-110.03M | 35.76%-152.23M | 72.65%-36.41M | -63.71%-236.97M | -37.89%-133.1M | 45.70%-144.75M | 23.19%-96.53M | -371.71%-266.58M |
| Operating expenses | 50.61%-54.35M | -6.18%-161.64M | -202.24%-110.03M | 35.76%-152.23M | 72.65%-36.41M | -63.71%-236.97M | -37.89%-133.1M | 45.70%-144.75M | 23.19%-96.53M | -371.71%-266.58M |
| Gross profit | -30.71%6.58M | -50.06%15.91M | 46.93%9.5M | 1,606.48%31.86M | 533.01%6.46M | -76.21%1.87M | -93.31%1.02M | -17.01%7.85M | 412.76%15.27M | 648.29%9.46M |
| Selling expenses | 67.93%-2.6M | -154.33%-10.71M | -650.32%-8.1M | -121.87%-4.21M | -25.17%-1.08M | -128.13%-1.9M | -152.79%-862K | 16.30%-832K | 87.16%-341K | 85.91%-994K |
| Impairment and provision | 135.88%7.29M | -25.21%-34.98M | ---20.33M | -1,680.75%-27.94M | ---- | 89.46%-1.57M | ---- | -1,150.13%-14.89M | ---- | 95.62%-1.19M |
| -Impairment of property, machinery and equipment | ---- | -1,334.10%-2.48M | ---- | 71.12%-173K | ---- | ---599K | ---- | ---- | ---- | ---- |
| -Other impairment is provision | 135.88%7.29M | -17.06%-32.5M | ---20.33M | -2,762.58%-27.77M | ---- | 93.49%-970K | ---- | -1,150.13%-14.89M | ---- | 86.54%-1.19M |
| Special items of operating profit | -2.32%-9.8M | -3.01%-23.8M | -1.38%-9.58M | -10.34%-23.1M | 14.72%-9.45M | 39.41%-20.94M | 48.99%-11.08M | -3.03%-34.55M | -78.09%-21.71M | 43.56%-33.54M |
| Operating profit | 105.19%1.48M | -129.06%-53.58M | -601.72%-28.5M | -3.80%-23.39M | 62.79%-4.06M | 46.88%-22.54M | -60.80%-10.92M | -61.54%-42.43M | 42.81%-6.79M | 72.46%-26.26M |
| Financing cost | 49.74%-96K | 9.46%-335K | -42.54%-191K | -17.83%-370K | 86.24%-134K | 87.38%-314K | 15.74%-974K | -44.12%-2.49M | -1,651.52%-1.16M | -202.98%-1.73M |
| Earning before tax | 104.82%1.38M | -126.90%-53.91M | -583.87%-28.7M | -3.99%-23.76M | 64.71%-4.2M | 49.13%-22.85M | -49.67%-11.89M | -60.46%-44.92M | 33.44%-7.95M | 70.82%-27.99M |
| Tax | 121.67%13K | 64.99%-1.82M | ---60K | -15,636.36%-5.19M | ---- | 97.99%-33K | 99.80%-8K | 3.97%-1.65M | -3,032.54%-3.95M | -42,725.00%-1.71M |
| After-tax profit from continuing operations | 104.86%1.4M | -92.48%-55.73M | -585.30%-28.76M | -26.54%-28.95M | 64.74%-4.2M | 50.85%-22.88M | -0.06%-11.9M | -56.75%-46.56M | 1.41%-11.89M | 69.04%-29.7M |
| After-tax profit from non-continuing business | ---- | -2,006.14%-41.15M | -3,819.43%-41.15M | 16.99%-1.95M | ---1.05M | 16.38%-2.35M | ---- | -199.47%-2.82M | -742.24%-3.31M | ---940K |
| Earning after tax | 102.00%1.4M | -213.47%-96.89M | -1,232.62%-69.91M | -22.48%-30.91M | 55.91%-5.25M | 48.89%-25.24M | 21.73%-11.9M | -61.12%-49.38M | -22.06%-15.2M | 68.06%-30.64M |
| Minority shareholders should account for profits from continuing business | -847.61%-2.97M | -36.76%1.32M | 1,426.92%397K | 214.13%2.08M | --26K | 78.61%-1.83M | ---- | -101.25%-8.54M | --5.91M | ---4.24M |
| Minority shareholders should account for non-continuing business profits | ---- | 62.80%-366K | 52.53%-366K | 43.35%-984K | ---771K | ---1.74M | ---- | ---- | ---- | ---- |
| Minority profit | -9,674.19%-2.97M | -13.45%952K | 104.16%31K | 130.87%1.1M | 42.34%-745K | 58.25%-3.56M | -121.87%-1.29M | -101.25%-8.54M | 366.13%5.91M | 77.69%-4.24M |
| Shareholders should account for profits from continuing business | 114.97%4.37M | -83.81%-57.05M | -590.48%-29.15M | -47.41%-31.04M | ---4.22M | 44.63%-21.06M | ---- | -49.33%-38.03M | ---17.8M | ---25.46M |
| Shareholders should account for profits from non-continuing business | ---- | -4,104.95%-40.79M | -14,519.35%-40.79M | -57.21%-970K | ---279K | 78.08%-617K | ---- | -199.47%-2.82M | ---3.31M | ---940K |
| Profit attributable to shareholders | 106.24%4.37M | -205.67%-97.84M | -1,453.88%-69.94M | -47.69%-32.01M | 57.57%-4.5M | 46.93%-21.67M | 49.75%-10.61M | -54.68%-40.84M | -106.25%-21.11M | 65.68%-26.4M |
| Basic earnings per share | 104.84%0.003 | -132.35%-0.079 | -1,140.00%-0.062 | -13.33%-0.034 | 66.67%-0.005 | 52.38%-0.03 | 54.55%-0.015 | -43.18%-0.063 | -1,000.00%-0.033 | -69.23%-0.044 |
| Diluted earnings per share | 104.84%0.003 | -132.35%-0.079 | -1,140.00%-0.062 | -13.33%-0.034 | 66.67%-0.005 | 52.38%-0.03 | 54.55%-0.015 | -43.18%-0.063 | -1,000.00%-0.033 | -69.23%-0.044 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Guowei Certified Public Accountants Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.